Heart failure Trials in Nantes, France
Conditions / Heart failure / Nantes, France
Clinical trials for Heart failure investigate a range of treatment strategies and patient populations.
47 total trials for this combination
Showing top 10 of 47 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02929329 | Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction | COMPLETED | PHASE3 |
| NCT02006069 | MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing | TERMINATED | NA |
| NCT06677060 | Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin | RECRUITING | PHASE3 |
| NCT03723265 | Personalized CRT - PSR | COMPLETED | — |
| NCT00271180 | Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products | RECRUITING | — |
| NCT03521934 | Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) | TERMINATED | PHASE3 |
| NCT06736574 | Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction | RECRUITING | PHASE3 |
| NCT02668250 | Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality | COMPLETED | NA |
| NCT00683696 | Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT) | TERMINATED | PHASE2/PHASE3 |
| NCT01877915 | A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure | COMPLETED | PHASE3 |